Search for other papers by Changwei Liu in
Google Scholar
PubMed
Search for other papers by Jingwen Wang in
Google Scholar
PubMed
Search for other papers by Yuanyuan Wan in
Google Scholar
PubMed
Search for other papers by Xiaona Xia in
Google Scholar
PubMed
Search for other papers by Jian Pan in
Google Scholar
PubMed
Search for other papers by Wei Gu in
Google Scholar
PubMed
Search for other papers by Mei Li in
Google Scholar
PubMed
Background Type 1 diabetes mellitus (T1DM) is an autoimmune disease occurring in the pancreatic islets. The disease can affect people of any age, but onset usually occurs in children or young adults, which accounts for 90% of diabetes in
Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Li Qian in
Google Scholar
PubMed
Search for other papers by Yuxiao Zhu in
Google Scholar
PubMed
Search for other papers by Yan Luo in
Google Scholar
PubMed
Search for other papers by Mu Zhang in
Google Scholar
PubMed
Search for other papers by Liping Yu in
Google Scholar
PubMed
Search for other papers by Yu Liu in
Google Scholar
PubMed
Search for other papers by Tao Yang in
Google Scholar
PubMed
Introduction Type 1 diabetes mellitus (T1DM) is well-defined as one of the most common and lifelong autoimmune diseases characterized by pancreatic β-cell destruction ( 1 , 2 ). Several autoantibodies, such as glutamic acid decarboxylase
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Marie Reeberg Sass in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark
Search for other papers by Nicolai Jacob Wewer Albrechtsen in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Endocrinology and Nephrology, Nordsjællands University Hospital, Hillerød, Denmark
Search for other papers by Jens Pedersen in
Google Scholar
PubMed
Search for other papers by Kristine Juul Hare in
Google Scholar
PubMed
Center for Neonatal Screening, Department of Congenital Disorders, Statens Serum Institute, Copenhagen, Denmark
Search for other papers by Nis Borbye-Lorenzen in
Google Scholar
PubMed
Search for other papers by Katalin Kiss in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Steno Diabetes Center Copenhagen, Gentofte, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Filip Krag Knop in
Google Scholar
PubMed
Search for other papers by Steen Seier Poulsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Niklas Rye Jørgensen in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Juul Holst in
Google Scholar
PubMed
Search for other papers by Cathrine Ørskov in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Bolette Hartmann in
Google Scholar
PubMed
with mean and s.d. For panel B, *represent statistical significant difference using an unpaired t -test, whereas for panel D, *represent statistical significant difference using a paired-test. Data are illustrated as mean ± s.e.m. n = 9/8 (T1DM
Search for other papers by W Liu in
Google Scholar
PubMed
Search for other papers by Y Wang in
Google Scholar
PubMed
Search for other papers by X Han in
Google Scholar
PubMed
Search for other papers by X Cai in
Google Scholar
PubMed
Search for other papers by Y Zhu in
Google Scholar
PubMed
Search for other papers by M Zhang in
Google Scholar
PubMed
Search for other papers by S Gong in
Google Scholar
PubMed
Search for other papers by J Li in
Google Scholar
PubMed
Search for other papers by L Ji in
Google Scholar
PubMed
Introduction Chronic complications cause the largest proportion of deaths and increase in prevalence with the duration of the disease in long-standing type 1 diabetes (T1DM). ( 1 ) Indeed, the duration of diabetes and severity of hyperglycemia
Search for other papers by Xiuzhen Zhang in
Google Scholar
PubMed
Search for other papers by Dan Xu in
Google Scholar
PubMed
Search for other papers by Ping Xu in
Google Scholar
PubMed
Search for other papers by Shufen Yang in
Google Scholar
PubMed
Search for other papers by Qingmei Zhang in
Google Scholar
PubMed
Search for other papers by Yan Wu in
Google Scholar
PubMed
Search for other papers by Fengyi Yuan in
Google Scholar
PubMed
Introduction Amongst the background of the rising incidence of type 1 diabetes mellitus (T1DM) across the globe, public concern has reached a new high ( 1 ). Despite progress in diabetes care, as the leading cause of mortality in T1DM ( 2
Postgraduation Program in Medical Sciences: Endocrinology, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Search for other papers by Taís S Assmann in
Google Scholar
PubMed
Search for other papers by Mariana Recamonde-Mendoza in
Google Scholar
PubMed
Postgraduation Program in Medical Sciences: Endocrinology, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Search for other papers by Bianca M De Souza in
Google Scholar
PubMed
Postgraduation Program in Medical Sciences: Endocrinology, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Search for other papers by Daisy Crispim in
Google Scholar
PubMed
Introduction Type 1 diabetes mellitus (T1DM) is characterized by autoimmune destruction of pancreatic beta-cells by T lymphocytes and macrophages ( 1 ). The disease is usually diagnosed when over 80–90% of beta-cells have been destructed by
Search for other papers by Stavroula A Paschou in
Google Scholar
PubMed
Search for other papers by Nektaria Papadopoulou-Marketou in
Google Scholar
PubMed
Search for other papers by George P Chrousos in
Google Scholar
PubMed
Search for other papers by Christina Kanaka-Gantenbein in
Google Scholar
PubMed
Introduction Type 1 diabetes mellitus (T1DM) represents only around 10% of the diabetes cases worldwide, but occurs with increasing incidence much earlier in life. T1DM results from the autoimmune destruction of β cells of the endocrine
Search for other papers by Yun Cai in
Google Scholar
PubMed
Search for other papers by Jieni Yan in
Google Scholar
PubMed
Search for other papers by Yong Gu in
Google Scholar
PubMed
Search for other papers by Heng Chen in
Google Scholar
PubMed
Search for other papers by Yang Chen in
Google Scholar
PubMed
Search for other papers by Xinyu Xu in
Google Scholar
PubMed
Search for other papers by Mei Zhang in
Google Scholar
PubMed
Search for other papers by Liping Yu in
Google Scholar
PubMed
Search for other papers by Xuqin Zheng in
Google Scholar
PubMed
Search for other papers by Tao Yang in
Google Scholar
PubMed
DM) is the most frequent ( 3 , 4 , 5 ). The phenotype is referred as autoimmune polyendocrine syndrome type II (APS II) when T1DM and AITD occur in the same individual, even sometimes coexist in the same family ( 6 , 7 ). T1DM, as well as AITD
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Lili Liu in
Google Scholar
PubMed
Search for other papers by Zhuo Shao in
Google Scholar
PubMed
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Ying Xia in
Google Scholar
PubMed
Search for other papers by Jiabi Qin in
Google Scholar
PubMed
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Yang Xiao in
Google Scholar
PubMed
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Zhiguang Zhou in
Google Scholar
PubMed
Search for other papers by Zubing Mei in
Google Scholar
PubMed
Introduction Type 1 diabetes mellitus (T1DM), which is caused by the selective destruction of the insulin-producing β cells located in the pancreatic islets of Langerhans, is one of the most common and debilitating autoimmune diseases ( 1
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Punith Kempegowda in
Google Scholar
PubMed
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Eka Melson in
Google Scholar
PubMed
Search for other papers by Agnes Johnson in
Google Scholar
PubMed
Search for other papers by Lucy Wallett in
Google Scholar
PubMed
Search for other papers by Lucretia Thomas in
Google Scholar
PubMed
Search for other papers by Dengyi Zhou in
Google Scholar
PubMed
Search for other papers by Catherine Holmes in
Google Scholar
PubMed
Search for other papers by Agata Juszczak in
Google Scholar
PubMed
Search for other papers by Mohammed Ali Karamat in
Google Scholar
PubMed
Search for other papers by Sandip Ghosh in
Google Scholar
PubMed
Search for other papers by Wasim Hanif in
Google Scholar
PubMed
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
Search for other papers by Parth Narendran in
Google Scholar
PubMed
School of Life and Health Sciences, Aston University, Birmingham, UK
Search for other papers by Srikanth Bellary in
Google Scholar
PubMed
times greater mortality from COVID-19 for those with type 2 diabetes (T2DM) and 3.5 times in those with type 1 diabetes mellitus (T1DM) compared to those without diabetes ( 2 ). Importantly, the majority of these deaths occurred in the elderly, and the